| | | | | Risk stratification in BAV aortopathy: new concepts
|
| | | | Allessandro Della Corte, Simon Body
|
| 08.30
| | | Genotype-based risk stratification of BAV disease: dream or reality? Simon Body |
| 08.40 | | | Implementing phenotype-based risk stratification of BAV aortopathy in surgical practice, Evaldas Girdauskas |
| 08.50 | | | Structural finite element modelling of the bicuspid root to understand disease progression, Emiliano Votta |
| 09.00 | | | Functional imaging of the BAV aorta to predict aortopathy progression, Malenka Bissell |
| 09.10 | | | Identifying circulating biomarkers of BAV aortopathy risk, Alessandro Della Cort |
| 09.20 | | | How to integrate imaging and biochemistry into risk stratification of bicuspid aortopathy, David Guzzardi |
| 09.30 | | | Questions to experts and discussion
|
| | | | Short communications from selected papers
|
| 09.35 | | | • Aortopathy in patients with a bicuspid aortic valve: a process beyond normal ardiovascular ageing, Nimrat Grewal |
| 09.40 | | | • The role of hemodynamics and shear stress on the ascending aortic wall in atients with a bicuspid aortic valve, Nimrat Grewal |
| | | | |
| 09.45
| | | Coffee break
|
| | | | |
| | | | | Ascending aorta
|
| | | | John Elefteriades, Jean-Olivier Defraigne
|
| 10.15
| | | The pathology of thoracic aortic aneurysm, Per Eriksson |
| 10.25 | | | Twenty-five year outcome of composite graft aortic root replacement: near “curative” impact on aortic root disease, John Elefteriades |
| 10.35 | | | Is there really research-based evidence for a guideline dimension for ascending aortic aneurysm repair? Simon Body |
| 10.45 | | | How to classify the dilatations of the ascending aorta? Alessandro Della Corte |
| 10.55 | | | Modeling of predissection aortic size in acute type A dissection: more than 90% fail to meet the guidelines for elective ascending replacement, Rita K Milewski |
| 11.05 | | | Management of aorto-ventricular tunnels: a rare cause (disregarded) of the heart failure in occidental countries. Single center experiences in HCMC,Vietnam, Dung Le Huu, Natzi Sakalihasan |
| 11.15 | | | Questions to experts and discussion
|
| | | | |
| 11.30 | | | Industry sponsored symposium (view here) |
| | | | |
| 12.30 | | | Lunch break
|
| | | | |
| | | | | Aortic arch
|
| | | | Firas Mussa, Jan Brunkwall
|
| 13.30 | | | Supraaortic debranching and TEVAR for arch aneurysms – is it a valid alternative for open surgery? (Single center series on › 50 pts), Hans-Henning Eckstein |
| 13.40 | | | Branched endograft vs. chimney techniques for treating complex arch lesions.
|
| | | | Which is best, when and why, Firas Mussa |
| 13.50 | | | Update on total arch endovascular repair, Rachel Clough |
| 14.00 | | | Various cardiac access routes to treat ascending aortic and arch lesions: advantages and limitations, Firas Mussa |
| 14.10 | | | Does the bovine arch have any influence on the outcome of arch stentgrafting in dissections? Jan Brunkwall |
| 14.20 | | | Distal aortic reintervention after surgery for acute DeBakey type I or II aortic dissection: open vs. endovascular repair, Rita K. Milewski |
| 14.30 | | | Keynote lecture. Hybrid stent-grafts: fac totum of open surgery of the aortic arch? Fabien Koskas |
| 14.40 | | | Discussion
|
| | | | Short communications from selected papers
|
| 14.50 | | | • Deep hypothermia with retrograde cerebral perfusion – as method of brain rotections in ascending aorta and arch aneurysms surgery, Vitalii Kravchenko |
| 14.55 | | | • Aneurysm at the site of repair of coarctation of aorta: frequency, methods of treatment, results, Vitalii Kravchenko |
| | | | |
| | | | | Aortic valves
|
| | | | Marc Radermecker, Victor Legrand
|
| 15.00 | | | TAVI indications, Luc Piérard |
| 15.10 | | | New imaging modalities for assessment of TAVI procedure and results, Helena Dulgheru |
| 15.20 | | | Critical analysis of recent registries and randomized trials, Victor Legrand |
| 15.30 | | | Choice of the best transcatheter site for implantation, Marc Radermecker |
| 15.40 | | | Off label indications: where are we? Thomas Modine |
| 15.50 | | | Antithrombotic treatment: DAPT or OAC? Pascal Vranckx |
| 16.00 | | | Rapid deployment aortic bioprosthesis in patients with small aortic annulus, Frédéric Collart |
| 16.10 | | | Valve fair: review of actual and future devices, Peter Frambach |
| 16.20 | | | New insight of percutaneous native aortic valve resection prior to TAVI, Parla Astarci |
| 16.30 | | | Sutureless aortic valve replacement: worldwide experience, Bart Meuris |
| 16.40 | | | Case report and discussion : Valve thrombosis after transcatheter aortic valve implantation, Rodolphe Durieux |
| 16.50 | | | Discussion
|
| | | | |
| 17.00 | | | Closing remarks & Awards ceremony
|
| | | | |
| 17.30 | | | Adjournment
|
| | | | |